Publication | Open Access
Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease
351
Citations
29
References
2011
Year
An adequately powered placebo-controlled trial of FOS showed no clinical benefit in patients with active Crohn's disease, despite impacting on DC function. ISRCTN50422530.
| Year | Citations | |
|---|---|---|
Page 1
Page 1